 |
|
|
| |
A Phase 2 Dose Ranging, Randomized, Double-blind and Placebo-Controlled Study of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
|
| |
| |
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Vlad Ratziu, Mary Rinella, Brent Neuschwander-Tetri, Eric Lawitz, Douglas Denham, ZeidKayali, AasimSheikh, Kris Kowdley, TaddeseDesta, Magdy Elkhashab, Jeffery DeGrauw, Alaa Ahmad, Kajal Larson,
Ty McClure, Nathalie Adda
|
| |
|
|
|
|
|
